News

We are extending the deadline of the consultation on synergies and complementarities between Horizon 2020 and European Structural and Investment Funds (ESIF) to Friday, 4 September 2020. Have your say now and help shape the next programming period!

Read more

Insight

The full report of the EOSC-Pillar National Initiatives Survey is now available on our Zenodo community.

Read more

News

The EOSC Executive Board is launching an open consultation on the EOSC Strategic Research and Innovation Agenda (SRIA). The consultation will run for 6 weeks over the summer, closing 31st August and will be in the form of an online questionnaire available on the EOSCSecretariat.eu website. Have your say and help us shape the future of the EOSC!

Read more

On 20th July, the EOSC Executive Board will open a public consultation aimed at defining the priorities of the future Strategic Research and Innovation Agenda (SRIA). It will take place on the EOSCsecretariat.eu website and will run for 6 weeks.

Read more

News

EOSC-Pillar is about to launch a consultation starting from 20 July, towards National initiatives and Member States on synergies and complementarities between Horizon 2020 and European Structural and Investment Funds (ESIF), in cooperation with ERA-Learn.

Read more

Insight

EOSC-Pillar has deployed its own Authentication and Authorization Infrastructure, thanks to the collaborative effort by Work Packages 7 and 6.

Read more

News

The EOSC-Pillar Zenodo Community is now online, find project deliverables and other documents!

Read more

Insight

The procedures to include national services in EOSC were released by our Work Package 7 and are now available on the EOSC-Pillar Zenodo community.

Read more

News

A recent article on EOSC by representatives of the National Research Council of Italy (one of EOSC-Pillar partners) was featured in the Italian APRE Magazine, published by the local Agency for the Promotion of European Research.

Read more

News

EU-funded consortium Exscalate4CoV - which features EOSC-Pillar partner Cineca and Fraunhofer - has announced that Raloxifene could be an effective treatment for COVID-19 patients with mildly symptomatic infection.

Read more

Pages